| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fc0668fd5cbfe23cea7d9bdd5de932a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
1992-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_846124c00c09d79d8b71c91149f61409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b82df21326407537f3c072747135d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37cb01375fe6225bd74727b437d7b973
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db46a20a55dc92e92da8529326321ed5 |
| publicationDate |
2000-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0596959-B1 |
| titleOfInvention |
Self-adjuvanting peptide vaccine delivery system and production thereof |
| abstract |
PCT No. PCT/AU92/00377 Sec. 371 Date May 3, 1994 Sec. 102(e) Date May 3, 1994 PCT Filed Jul. 24, 1992 PCT Pub. No. WO93/02706 PCT Pub. Date Feb. 18, 1993The present invention provides self-adjuvanting vaccines for use in raising antibodies to peptides without the use of oil or alum adjuvants. Further, the present invention provides methods of therapy using these vaccines and has particular application in chemical castration. In one aspect the vaccine comprises in admixture a peptide conjugated to 1-3 fatty acids and a peptide conjugated to a carrier protein. In preferred forms the peptide is conjugated to the fatty acids via a tromethamine or ethanolamine derivative. The preferred protein carrier is Type 4 fimbriae. |
| priorityDate |
1991-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |